English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Infections of the central nervous system present the most significant challenge in our attempt to combat infectious diseases. Part of our inability to counter these diseases is attributed to an incomplete understanding of (i) how infectious agents cross the blood-brain barrier, a key step in the development of CNS infections, and (ii) the inability of drugs to traverse the blood-brain barrier to gain entry into the brain to kill parasites. Thus, there is an urgent need to expedite both drug discovery and drug delivery programmes. Here, we describe the use of in vitro, ex vivo, and in vivo models of the blood-brain barrier to examine the physical barriers, cellular mechanisms and molecular elements participating from both sides of the parasite-host interactions. In addition, these models provide useful screening tools to give rough indications of the potential of new antimicrobial agents with respect to efficacy, optimal routes of administration, and toxicity.

Non-Mammalian Models to Study Infections of the Central Nervous System and to Screen Potential Therapeutic Agents